Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
24.21
-0.95 (-3.78%)
At close: Nov 6, 2026, 4:00 PM EST
24.29
+0.08 (0.33%)
Pre-market: Nov 9, 2026, 4:15 AM EST

Collegium Pharmaceutical Revenue

Collegium Pharmaceutical had revenue of $216.34M in the quarter ending September 30, 2026, with 3.33% growth. This brings the company's total for the last twelve months to $815.19M, up 7.68% year-over-year. In the year 2025, Collegium Pharmaceutical had annual revenue of $780.57M with 23.62% growth. That makes Collegium Pharmaceutical the 8,629th largest company in the world by revenue and 1,937th in the United States.

Revenue (ttm)
$815.19M
Revenue Growth
+7.68%
P/S Ratio
0.92
Revenue / Employee
$1,927,154
Employees
423
Market Cap
752.34M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025780.57M149.12M23.62%
Dec 31, 2024631.45M64.68M11.41%
Dec 31, 2023566.77M102.83M22.17%
Dec 31, 2022463.93M187.07M67.56%
Dec 31, 2021276.87M-33.15M-10.69%
Dec 31, 2020310.02M13.32M4.49%
Dec 31, 2019296.70M16.29M5.81%
Dec 31, 2018280.41M251.94M884.73%
Dec 31, 201728.48M26.77M1,564.29%
Dec 31, 20161.71M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Phibro Animal Health1.54B
Tilray Brands963.10M
Evotec SE815.72M
Amphastar Pharmaceuticals745.79M
Ironwood Pharmaceuticals400.30M
Evolus325.47M
Harrow275.59M
Cronos Group206.20M
Revenue Rankings